Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma

NCT04437329 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

352

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: Docetaxel, nedaplatin, fluorouracil
DRUG: Docetaxel, cisplatin, fluorouracil
DRUG: Nedaplatin
DRUG: Cisplatin
RADIATION: Intensity modulated-radiotherapy

Sponsor

Affiliated Cancer Hospital & Institute of Guangzhou Medical University